Hedge Fund News From HedgeCo.Net

Steven Cohen Storms into Progenics Pharmaceuticals

January 6, 2019 : Permanent Link

(Guru Focus) Steven Cohen, manager of Point72 Asset Management, disclosed this week he took a position in Progenics Pharmaceuticals Inc. increasing his portfolio’s exposure to the health care sector.

To read this article:

This entry was posted in Syndicated. Bookmark the permalink.

Leave a Reply

Recent Posts

  1. Stock futures fall after Meta Platforms, IBM report quarterly results: Live updates
  2. Meta loses $200 billion in value as Zuckerberg focuses earnings call on all the ways company bleeds cash
  3. IBM to acquire HashiCorp in $6.4 billion deal, reports another revenue miss
  4. JPMorgan Chase is caught in U.S-Russia sanctions war after overseas court orders $440 million seized from bank
  5. Rubrik prices IPO at $32 per share, above the expected range

Search


Categories